{"pmid":32428303,"title":"COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists.","text":["COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists.","As of the 11(th) of March, the world health organization (WHO) declared Coronavirus disease-2019 (COVID-19) as a pandemic disease caused by SARS-CoV-2 (previously known as 2019-nCOV) (1,2). By the 19(th) of April, 2,241,778 confirmed patients were reported worldwide with 152,552 COVID-19 related deaths (3). The COVID-19 pandemic represents the most serious health crisis facing the modern world resulting in unprecedented efforts to contain this pandemic and its consequences (1).","J Eur Acad Dermatol Venereol","Fahmy, Dina Hassan","El-Amawy, Heba Saed","El-Samongy, Marwa Ahmed","Foud, Aya Ashraf","Soliman, Sarah Hamdy","El-Kady, Aya","Farnetani, Francesca","Conti, Andrea","Zoeir, Ahmed","Eissa, Ahmed","Eissa, Radwa","Puliatti, Stefano","Sighinolfi, Maria Chiara","Rocco, Bernardo","Pellacani, Giovanni","32428303"],"abstract":["As of the 11(th) of March, the world health organization (WHO) declared Coronavirus disease-2019 (COVID-19) as a pandemic disease caused by SARS-CoV-2 (previously known as 2019-nCOV) (1,2). By the 19(th) of April, 2,241,778 confirmed patients were reported worldwide with 152,552 COVID-19 related deaths (3). The COVID-19 pandemic represents the most serious health crisis facing the modern world resulting in unprecedented efforts to contain this pandemic and its consequences (1)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Fahmy, Dina Hassan","El-Amawy, Heba Saed","El-Samongy, Marwa Ahmed","Foud, Aya Ashraf","Soliman, Sarah Hamdy","El-Kady, Aya","Farnetani, Francesca","Conti, Andrea","Zoeir, Ahmed","Eissa, Ahmed","Eissa, Radwa","Puliatti, Stefano","Sighinolfi, Maria Chiara","Rocco, Bernardo","Pellacani, Giovanni"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428303","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jdv.16545","topics":["Prevention"],"weight":1,"_version_":1667352728722997248,"score":9.490897,"similar":[{"pmid":32270500,"title":"Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","text":["Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang","32270500"],"abstract":["Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270500","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25849","topics":["Case Report"],"weight":1,"_version_":1666138491741798400,"score":97.50446},{"pmid":32447820,"title":"Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.","text":["Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.","The world entered the year 2020 with reports of the emergence of a new viral illness in Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified to be the causative novel coronavirus for the cluster of patients suffering from pneumonia in China. The disease was later named as coronavirus disease (COVID-19) and was declared a pandemic by the World Health Organization on March 11, 2020. Several studies, since then, have tried to study and explain the origin of SARS-CoV-2, its structure and pathogenicity, epidemiology, modes of transmission, spectrum of illness and causes of mortality and morbidity. The current management strategies focus on supportive care and prevention of complications. With no definite treatment, as of now, encouraging reports of some anti-viral and anti-malarial drugs in the management of COVID-19 generate some hope. This review intends to cover the current known aspects of COVID-19 and SARS-CoV-19, based on the available literature.","Dermatol Ther","Kaur, Ishmeet","Sharma, Aseem","Jakhar, Deepak","Das, Anupam","Aradhya, Sujala Sacchidanand","Sharma, Rashmi","Jindal, Veenu","Mhatre, Madhulika","32447820"],"abstract":["The world entered the year 2020 with reports of the emergence of a new viral illness in Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified to be the causative novel coronavirus for the cluster of patients suffering from pneumonia in China. The disease was later named as coronavirus disease (COVID-19) and was declared a pandemic by the World Health Organization on March 11, 2020. Several studies, since then, have tried to study and explain the origin of SARS-CoV-2, its structure and pathogenicity, epidemiology, modes of transmission, spectrum of illness and causes of mortality and morbidity. The current management strategies focus on supportive care and prevention of complications. With no definite treatment, as of now, encouraging reports of some anti-viral and anti-malarial drugs in the management of COVID-19 generate some hope. This review intends to cover the current known aspects of COVID-19 and SARS-CoV-19, based on the available literature."],"journal":"Dermatol Ther","authors":["Kaur, Ishmeet","Sharma, Aseem","Jakhar, Deepak","Das, Anupam","Aradhya, Sujala Sacchidanand","Sharma, Rashmi","Jindal, Veenu","Mhatre, Madhulika"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447820","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13677","keywords":["mers","sars-cov-2","acute respiratory distress syndrome (ards)","coronavirus disease; covid-19; sars","pandemic","pneumonia"],"locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism","Transmission","Diagnosis","Prevention"],"weight":1,"_version_":1667698385907351552,"score":90.748726},{"pmid":32385672,"title":"COVID-19 and Cancer: a Comprehensive Review.","text":["COVID-19 and Cancer: a Comprehensive Review.","PURPOSE OF REVIEW: The outbreak of the novel coronavirus disease 2019 (COVID-19) has emerged to be the biggest global health threat worldwide, which has now infected over 1.7 million people and claimed more than 100,000 lives around the world. Under these unprecedented circumstances, there are no well-established guidelines for cancer patients. RECENT FINDINGS: The risk for serious disease and death in COVID-19 cases increases with advancing age and presence of comorbid health conditions. Since the emergence of the first case in Wuhan, China, in December 2019, tremendous research efforts have been underway to understand the mechanisms of infectivity and transmissibility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a fatal virus responsible for abysmal survival outcomes. To minimize the mortality rate, it becomes prudent to identify symptoms promptly and employ treatments appropriately. Even though no cure has been established, multiple clinical trials are underway to determine the most optimal strategy. Managing cancer patients under these circumstances is rather challenging, given their vulnerable status and the aggressive nature of their underlying disease. In this comprehensive review, we discuss the impact of COVID-19 on health and the immune system of those affected, reviewing the latest treatment approaches and ongoing clinical trials. Additionally, we discuss challenges faced while treating cancer patients and propose potential approaches to manage this vulnerable population during this pandemic.","Curr Oncol Rep","Gosain, Rohit","Abdou, Yara","Singh, Abhay","Rana, Navpreet","Puzanov, Igor","Ernstoff, Marc S","32385672"],"abstract":["PURPOSE OF REVIEW: The outbreak of the novel coronavirus disease 2019 (COVID-19) has emerged to be the biggest global health threat worldwide, which has now infected over 1.7 million people and claimed more than 100,000 lives around the world. Under these unprecedented circumstances, there are no well-established guidelines for cancer patients. RECENT FINDINGS: The risk for serious disease and death in COVID-19 cases increases with advancing age and presence of comorbid health conditions. Since the emergence of the first case in Wuhan, China, in December 2019, tremendous research efforts have been underway to understand the mechanisms of infectivity and transmissibility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a fatal virus responsible for abysmal survival outcomes. To minimize the mortality rate, it becomes prudent to identify symptoms promptly and employ treatments appropriately. Even though no cure has been established, multiple clinical trials are underway to determine the most optimal strategy. Managing cancer patients under these circumstances is rather challenging, given their vulnerable status and the aggressive nature of their underlying disease. In this comprehensive review, we discuss the impact of COVID-19 on health and the immune system of those affected, reviewing the latest treatment approaches and ongoing clinical trials. Additionally, we discuss challenges faced while treating cancer patients and propose potential approaches to manage this vulnerable population during this pandemic."],"journal":"Curr Oncol Rep","authors":["Gosain, Rohit","Abdou, Yara","Singh, Abhay","Rana, Navpreet","Puzanov, Igor","Ernstoff, Marc S"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32385672","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s11912-020-00934-7","keywords":["ace2","ards","covid-19","cancer","coronavirus","immune response","pandemic","pneumonia","sars","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666340101980946432,"score":89.058105},{"pmid":32316337,"title":"COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori \"Giovanni Paolo II\" of Bari.","text":["COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori \"Giovanni Paolo II\" of Bari.","On 11 March 2020, the World Health Organization declared a new disease caused by a novel virus characterized by rapid human-to-human transmission and named severe acute respiratory syndrome coronoavirus-2 (SARS-CoV-2) a pandemic. In terms of this ongoing international scenario, we report the situation in Apulia, a region of southern Italy that, as of April 2, has not yet been overwhelmed by this health emergency. In particular, we consider the care models that have been adopted, especially those that manage the requests of cancer patients.","Int J Environ Res Public Health","Silvestris, Nicola","Moschetta, Antonio","Paradiso, Angelo","Delvino, Antonio","32316337"],"abstract":["On 11 March 2020, the World Health Organization declared a new disease caused by a novel virus characterized by rapid human-to-human transmission and named severe acute respiratory syndrome coronoavirus-2 (SARS-CoV-2) a pandemic. In terms of this ongoing international scenario, we report the situation in Apulia, a region of southern Italy that, as of April 2, has not yet been overwhelmed by this health emergency. In particular, we consider the care models that have been adopted, especially those that manage the requests of cancer patients."],"journal":"Int J Environ Res Public Health","authors":["Silvestris, Nicola","Moschetta, Antonio","Paradiso, Angelo","Delvino, Antonio"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32316337","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3390/ijerph17082763","keywords":["covid-19","cancer patient","health system","pandemic"],"locations":["Apulia","Italy","Bari"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493693198337,"score":86.653694},{"pmid":32365277,"title":"New emerging dermatological symptoms in coronavirus pandemic.","text":["New emerging dermatological symptoms in coronavirus pandemic.","COVID-19 (Coronavirus Disease 2019) is a fatal disease that could lead to a serious respiratory illness. It is caused by SARS-CoV-2 virus. In December 2019, the first of human cases were identified in China and the infection spread quickly around the world. The World Health Organisation (WHO) declared the disease, a global pandemic on 11 March 2020, even as COVID-19 rapidly spread across the world. According to clinical reports, fever, headache, cough and myalgia are common clinical symptoms. Many symptoms also occur, such as sputum formation, haemoptysis and diarrhea.","J Cosmet Dermatol","Gupta, Gaurav","Singh, Yogendra","Kumar Chellappan, Dinesh","Dua, Kamal","32365277"],"abstract":["COVID-19 (Coronavirus Disease 2019) is a fatal disease that could lead to a serious respiratory illness. It is caused by SARS-CoV-2 virus. In December 2019, the first of human cases were identified in China and the infection spread quickly around the world. The World Health Organisation (WHO) declared the disease, a global pandemic on 11 March 2020, even as COVID-19 rapidly spread across the world. According to clinical reports, fever, headache, cough and myalgia are common clinical symptoms. Many symptoms also occur, such as sputum formation, haemoptysis and diarrhea."],"journal":"J Cosmet Dermatol","authors":["Gupta, Gaurav","Singh, Yogendra","Kumar Chellappan, Dinesh","Dua, Kamal"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365277","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jocd.13466","locations":["China","fever","headache","myalgia","haemoptysis","diarrhea"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495954976770,"score":86.295006}]}